These compounds may interact with:
Orexin receptor type 2
Potentially involved in: melanoma; kidney cancer; carcinoma; liver cancer; skin cancer; acquired immunodeficiency syndrome; narcolepsy; cannabis dependence; heroin dependence; insomnia
Disease data sourced from Pharos.